John Hohneker - 23 Sep 2022 Form 4 Insider Report for Aravive, Inc.

Role
Director
Signature
/s/ Abel Svitavsky, Attorney-In-Fact
Issuer symbol
N/A
Transactions as of
23 Sep 2022
Net transactions value
$0
Form type
4
Filing time
26 Sep 2022, 16:06:05 UTC
Previous filing
29 Jul 2022
Next filing
24 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARAV Stock Option (Right to Buy) Award $0 +97,063 $0.000000 97,063 23 Sep 2022 Common Stock 97,063 $0.9152 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest pro rata on a monthly basis commencing on October 23,2022 for the next 12 months with full vesting, if not fully vested at such time, on the date of Aravive, Inc.'s next annual meeting of stockholders.